Form 8-K - Current report:
SEC Accession No. 0001171843-24-001127
Filing Date
2024-03-01
Accepted
2024-03-01 17:00:16
Documents
14
Period of Report
2024-02-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_030124.htm   iXBRL 8-K 23985
  Complete submission text file 0001171843-24-001127.txt   197455

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE apto-20240229.xsd EX-101.SCH 3030
3 XBRL LABEL FILE apto-20240229_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE apto-20240229_pre.xml EX-101.PRE 22369
15 EXTRACTED XBRL INSTANCE DOCUMENT f8k_030124_htm.xml XML 3723
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 24711282
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)